| ISIN | LU1096900078 |
|---|---|
| Valor Number | 25115435 |
| Bloomberg Global ID | |
| Fund Name | JSS Equity - Europe P USD acc |
| Fund Provider |
J. Safra Sarasin Investmentfonds AG
Basel, Switzerland Phone: +41 58 317 44 44 Web: www.jsafrasarasin.com |
| Fund Provider | J. Safra Sarasin Investmentfonds AG |
| Representative in Switzerland |
J. Safra Sarasin Investmentfonds AG Basel Phone: +41 58 317 44 00 |
| Distributor(s) |
Bank J. Safra Sarasin AG Basel Phone: +41 58 317 44 00 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The investment objective of the fund is long-term capital appreciation through a Europewide, diversified investment in equities. |
| Peculiarities |
| Current Price * | 145.77 USD | 23.10.2025 |
|---|---|---|
| Previous Price * | 145.53 USD | 22.10.2025 |
| 52 Week High * | 146.87 USD | 16.10.2025 |
| 52 Week Low * | 114.64 USD | 07.04.2025 |
| NAV * | 145.77 USD | 23.10.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 55,223,068 | |
| Unit/Share Assets *** | 1,346,504 | |
| Trading Information SIX | ||
| YTD Performance | +20.17% |
31.12.2024 - 23.10.2025
31.12.2024 23.10.2025 |
|---|---|---|
| YTD Performance (in CHF) | +5.32% |
31.12.2024 - 23.10.2025
31.12.2024 23.10.2025 |
| 1 month | +2.00% |
23.09.2025 - 23.10.2025
23.09.2025 23.10.2025 |
| 3 months | +3.73% |
23.07.2025 - 23.10.2025
23.07.2025 23.10.2025 |
| 6 months | +12.71% |
23.04.2025 - 23.10.2025
23.04.2025 23.10.2025 |
| 1 year | +10.96% |
23.10.2024 - 23.10.2025
23.10.2024 23.10.2025 |
| 2 years | +29.00% |
23.10.2023 - 23.10.2025
23.10.2023 23.10.2025 |
| 3 years | +49.20% |
24.10.2022 - 23.10.2025
24.10.2022 23.10.2025 |
| 5 years | +37.65% |
23.10.2020 - 23.10.2025
23.10.2020 23.10.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AstraZeneca PLC | 4.40% | |
|---|---|---|
| Allianz SE | 4.19% | |
| ASML Holding NV | 3.60% | |
| Bankinter SA | 3.55% | |
| Nordea Bank Abp | 3.50% | |
| TotalEnergies SE | 3.40% | |
| Amadeus IT Group SA | 3.31% | |
| KONE Oyj Class B | 3.22% | |
| L'Oreal SA | 3.22% | |
| ASR Nederland NV | 3.01% | |
| Last data update | 31.08.2025 | |
| TER | 1.70% |
|---|---|
| TER date | 30.06.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.75% |
| Ongoing Charges *** | 1.70% |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2025 |